The network access control (NAC) platform also ensures that OSN’s network is BYOD-ready; important, due to the company’s plans to fully embrace BYOD and mobility in the near future.
Ronald D’sa, IT Manager for OSN, said, “We required a product that gave us control of wired and wireless guest and contractors’ devices, as well as full visibility of all employee systems in a seamless manner so that contractors and employees can remain productive. CounterACT provides this, and more, giving us a substantive layer of real-time security.”
Prior to NAC deployment, OSN was controlling its network access and endpoint compliance more manually, which was time consuming and unproductive. CounterACT automated a broad array of IT processes, yielding annual cost savings of up to $36,000.
Ronald D’sa commented, “Last year we were spending a lot of man hours identifying non-compliant devices and guest devices – it was a challenging task. ForeScout’s NAC product requires far less resources to manage, in fact now one person can manage all devices across the entire region. Best of all, we were able to successfully roll out the solution quickly and found it extremely extensible.”
Dubai-based Nanjgel Solutions carried out a successful proof-of-concept across OSN’s complex, heterogeneous network environment, which incorporates Juniper, Cisco Foundry and Brocade infrastructure. Nanjgel then fully deployed CounterACT within a week, going live in January.
“In addition to providing enterprises like OSN with complete network visibility, CounterACT also delivers continuous security posture-checking, endpoint compliance, and protection from zero-day threats via our patented ActiveResponse technology. Our functional breadth always exceeds our customers’ expectations. We welcome organisations across EMEA to see just how versatile and valuable CounterACT can be by testing it for themselves,” said John Hagerty, EMEA sales director for ForeScout.
Saturday, January 26- 2013 @ 15:39 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.